Together, these data suggest an association of MyD88 and a panel of TLRs (i.e., TLR1, TLR2, TLR4, TLR5, TLR8, and TLR9) with disease progression in patients with COVID-19 [149]. This evidence concerns the gene TLR2 and COVID-19.